Skip to content

Clinical trials

Phase 1/2 beta-Thalassemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: beta-Thalassemia Phase: Phase 1/2 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20081
20092
20111
20131
20151
20171
20182
20201
20223
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting5
Recruiting3
Unknown status2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)3
Bioray Laboratories1
Children's Hospital of Philadelphia1
Editas Medicine, Inc.1
Genetix Biotherapeutics Inc.1
Genzyme, a Sanofi Company1
HemaQuest Pharmaceuticals Inc.1
IRCCS San Raffaele1
Lantu Biopharma1
Nanfang Hospital, Southern Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
beta-Thalassemia18
Anemia, Sickle Cell8
Anemia, Diamond-Blackfan2
Thalassemia2
Anemia1
Anemia, Aplastic1
Anemia, Hemolytic, Congenital1
Bone Marrow Failure Disorders1
Hemoglobinopathies1
Myelodysplastic Syndromes1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.